
Presentation title
Update on Haemochromatosis Arthropathy, classification criteria and the role of iron.
Clinical interests
Professor Kiely is a Consultant Rheumatologist and Professor of Practice in Clinical Rheumatology. He is a general rheumatologist and runs specialist clinics in difficult to manage rheumatoid arthritis, idiopathic inflammatory myositis (inflammatory muscle disease), vasculitis and interstitial lung disease associated with rheumatic diseases. He also runs the only UK national clinic for people with Haemochromatosis Arthropathy.
Professional profile
Professor Kiely qualified in medicine from Middlesex Hospital and University College London in 1988. He received a PhD from the University of Cambridge in 1996, completed specialist training in Rheumatology and General Internal Medicine in 1998, and was awarded FRCP in 2003. He has been a consultant at St George’s University Hospitals NHS Foundation Trust since 1999 and also Somerset NHS Foundation Trust since 2024. In 2020 he became Professor of Practice in Clinical Rheumatology at St George’s, University of London.
He has a particular interest in Haemochromatosis Arthropathy, establishing the only national UK Rheumatology clinic for people with this condition in 2012. He has published work on the clinical features and joint distribution of arthropathy in Haemochromatosis and the MRI appearance of ankle arthritis. He has led the European League against Rheumatism (EULAR) international task force on Haemochromatosis Arthropathy since 2020, recently publishing the first classification criteria for this condition.
He also has research interests in the fields of outcomes and optimisation of therapies for people with inflammatory arthritis, especially biologic and JAK inhibitors, and has published over 100 original research and review articles. He was a co-author of the 2009 NICE rheumatoid arthritis clinical guideline. He has been a member of guideline development groups for the British Society for Rheumatology (BSR) for myositis and EULAR for biopharmaceutical monitoring.
He lectures widely in the UK and overseas on his areas of specialist interest and since 2008 has organised triannual educational meetings for consultant rheumatologists in London (South), Surrey, Sussex and Kent.
Ex-council and external affairs committee member, British Society of Rheumatology
Member: British Society of Rheumatology
Medical Advisor: National Rheumatoid Arthritis Society
Medical Advisor: Haemochromatosis UK
Executive member: Early Rheumatoid Arthritis Network
Ex-Associate Editor ‘Rheumatology’ 2017 – 2020
Ex-clinical director for out-patient services, St George’s, 2009-2015
